Int J Stomatol

Inter J Stomatol ›› 2015, Vol. 42 ›› Issue (1): 24-27.doi: 10.7518/gjkq.2015.01.007

Previous Articles     Next Articles

Therapeutic evaluation of Zhongtongan in the treatment of temporomandibular joint pain after radiotherapy

Chen Qi, Wu Yun   

  1. Dept. of Stomatology, Chengdu Third People’s Hospital, Chengdu 610031, China
  • Online:2015-01-01 Published:2015-01-01

RichHTML

5

PDF (PC)

1029

Abstract:

Objective This study aims to evaluate the effect of Zhongtongan in the treatment of temporomandibular joint(TMJ) pain after radiotherapy. Methods Patients diagnosed with TMJ pain after radiotherapy were selected. The test groups are treated with Zhongtongan, whereas the control groups were separately treated with ibuprofen and vitamin E. Visual analog scale values of pain and range of motion were observedalong with adverse drug reactions. Results Zhongtongan or ibuprofen alleviated the degree of TMJ pain and improved the range of motion. No significant difference was found between the effects of the two drugs. The adverse drug reactions of ibuprofen were more serious than those of Zhongtongan. A significant difference was found between the two drugs in terms of adverse drug reaction. Conclusion The effect of Zhongtongan in the treatment of TMJ pain was confirmed. Compared with non-steroidal anti-inflammatory drugs, Zhongtongan was found to be safer and has lessadverse drug reactions than ibuprofen. Furthermore, Zhongtongan can be used as an alternative medicine for patients intolerant to non-steroidal anti-inflammatory drugs.

Key words: Zhongtongan, radiotherapy, temporomandibular joint pain


TrendMD: 
[1] He Zimu, Li Fenglan. Present application of digital oral positioning stents in radiotherapy of head and neck tumor [J]. Int J Stomatol, 2024, 51(1): 28-35.
[2] Yang Mingyan,Zhang Fan,Zhao Lei. Research progress on oral flora changes affecting the course of radiotherapy and chemotherapy-related oral mucositis [J]. Int J Stomatol, 2023, 50(1): 43-51.
[3] Chen Xiaoli,Zhang Fan,Liu Chengcheng. Application progress on photobiomodulation in the prevention and treatment of oral complications after radiothe-rapy [J]. Int J Stomatol, 2022, 49(6): 707-716.
[4] Li Hongfang,Chen Zhong,Zhang Suxin.. Research progress on immune checkpoint inhibitor combined with radiotherapy in head and neck squamous cell carcinoma [J]. Int J Stomatol, 2022, 49(5): 614-620.
[5] Wei Binbin,Hu Huiwei,Liu Yujuan,Sun Zhe,Yi Yuli. Meta-analysis and GRADE evaluation of the intervention effects of using amifostine before radiotherapy on xerostomia in patients with head and neck cancer [J]. Int J Stomatol, 2020, 47(5): 547-556.
[6] Chen Dong,Yang Zheng,Jiang Li. Research progress on the evaluation and management of radiation-induced xerostomia [J]. Int J Stomatol, 2019, 46(6): 711-717.
[7] Liu Pan1, Duolikun?Wufuer1, Cai Zhigang2, Sun Jian3. Clinical significance of serum squamous cell carcinoma antigens in Uyghur patients with oral squamous cell carcinoma [J]. Inter J Stomatol, 2016, 43(6): 645-650.
[8] Lü Danni, Li Ronglin, Yang Guangwei, Li Chunyang. Prevention and treatment of radiation- and chemotherapy-induced oral mucositis [J]. Inter J Stomatol, 2015, 42(2): 177-180.
[9] WANG Ya-min, SONG Guang-bao.. The effects of radiotherapy on oral implantation [J]. Inter J Stomatol, 2011, 38(2): 204-206.
[10] XIA Yong, NONG Xiao-lin. Advances in treatment of salivary gland malignant tumor [J]. Inter J Stomatol, 2009, 36(1): 46-46～49.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 458 -460 .
[8] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 452 -454 .
[9] . [J]. Inter J Stomatol, 2008, 35(S1): .
[10] . [J]. Inter J Stomatol, 2008, 35(S1): .